These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29681172)

  • 1. Analyzing the Potential of Advanced Insulin Dosing Strategies in Patients With Type 2 Diabetes: Results From a Hybrid In Silico Study.
    Reiterer F; Reiter M; Del Re L; Bechmann Christensen M; Nørgaard K
    J Diabetes Sci Technol; 2018 Sep; 12(5):1029-1040. PubMed ID: 29681172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
    Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
    Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and Time Delay of Glucose Measurements of Continuous Glucose Monitoring and Bedside Artificial Pancreas During Hyperglycemic and Euglycemic Hyperinsulinemic Glucose Clamp Study.
    Kuroda A; Taniguchi S; Akehi Y; Mori H; Tamaki M; Suzuki R; Otsuka Y; Matsuhisa M
    J Diabetes Sci Technol; 2017 Nov; 11(6):1096-1100. PubMed ID: 28992720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
    Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
    Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring.
    Kovatchev BP; Patek SD; Ortiz EA; Breton MD
    Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
    Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
    Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring.
    Pettus J; Edelman SV
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S234-42. PubMed ID: 26784128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
    Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
    J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.
    Sánchez-Peña R; Colmegna P; Garelli F; De Battista H; García-Violini D; Moscoso-Vásquez M; Rosales N; Fushimi E; Campos-Náñez E; Breton M; Beruto V; Scibona P; Rodriguez C; Giunta J; Simonovich V; Belloso WH; Cherñavvsky D; Grosembacher L
    J Diabetes Sci Technol; 2018 Sep; 12(5):914-925. PubMed ID: 29998754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
    Apablaza P; Soto N; Codner E
    Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.